These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Role of certain mechanisms in the pathogenesis of emphysema and a number of other lung diseases]. Putov NV; Pokhodzeĭ IV; Kolodkina LA Ter Arkh; 1985; 57(3):144-8. PubMed ID: 3890255 [No Abstract] [Full Text] [Related]
4. [Therapeutic possibilities in the management of antitrypsin-deficient pulmonary emphysema]. Tarján E; Pitlik E Orv Hetil; 1991 Sep; 132(36):1975-8, 1981-2. PubMed ID: 1923469 [TBL] [Abstract][Full Text] [Related]
5. The pallid mouse. A model of genetic alpha 1-antitrypsin deficiency. Martorana PA; Brand T; Gardi C; van Even P; de Santi MM; Calzoni P; Marcolongo P; Lungarella G Lab Invest; 1993 Feb; 68(2):233-41. PubMed ID: 8441253 [TBL] [Abstract][Full Text] [Related]
6. [Genetic and acquired alpha 1-antitrypsin deficiency and development of pulmonary emphysema]. Pedersen CF Ugeskr Laeger; 1984 Sep; 146(37):2770-2. PubMed ID: 6334920 [No Abstract] [Full Text] [Related]
7. [New theories on the role of genetically determined alpha 1-antitrypsindeficiency in the development of pulmonary emphysema]. Piłacik B; Hanke W Pol Tyg Lek; 1990 Sep 17-24; 45(38-39):798-800. PubMed ID: 2095551 [No Abstract] [Full Text] [Related]
8. Oxidants, antioxidants and the pathogenesis of emphysema. Cantin A; Crystal RG Eur J Respir Dis Suppl; 1985; 139():7-17. PubMed ID: 2995106 [TBL] [Abstract][Full Text] [Related]
9. [Current views on the pathogenesis and treatment of pulmonary emphysema and chronic bronchitis]. Fal A Wiad Lek; 1992 Mar; 45(5-6):233-9. PubMed ID: 1455869 [TBL] [Abstract][Full Text] [Related]
10. Antiproteinase deficiency, emphysema and replacement therapy. Burdon JG; Knight KR; Brenton S; Cook L Aust N Z J Med; 1996 Dec; 26(6):769-71. PubMed ID: 9028505 [No Abstract] [Full Text] [Related]
11. [Cigarette smoking and the etiopathogenesis of pulmonary emphysema]. Górecka D Pneumonol Pol; 1984 Jul; 52(7):353-7. PubMed ID: 6387638 [No Abstract] [Full Text] [Related]
12. Alpha 1-antitrypsin, emphysema and smoking. Carrell RW N Z Med J; 1984 May; 97(756):327-8. PubMed ID: 6610142 [No Abstract] [Full Text] [Related]
14. [Possibilities of the prevention and treatment of pulmonary emphysema in the light of the "proteolytic" theory of its pathogenesis]. Nowak D Pneumonol Pol; 1985 Oct; 53(10):492-6. PubMed ID: 3912732 [No Abstract] [Full Text] [Related]
15. Pathogenesis of COPD. Part I. The role of protease-antiprotease imbalance in emphysema. Abboud RT; Vimalanathan S Int J Tuberc Lung Dis; 2008 Apr; 12(4):361-7. PubMed ID: 18371259 [TBL] [Abstract][Full Text] [Related]
16. A rare case of pulmonary emphysema. Sotcan M; Copaci I; Enache M; Jurcuţ C; Duţescu V; Rusu C Rom J Intern Med; 2006; 44(4):465-70. PubMed ID: 18386623 [TBL] [Abstract][Full Text] [Related]
17. [Prolastin in the treatment of mild emphysema in patients with alpha 1-protease inhibitor deficiency]. Ulrik CS; Dirksen A; Kok-Jensen A Ugeskr Laeger; 1992 Mar; 154(12):811-2. PubMed ID: 1553776 [No Abstract] [Full Text] [Related]
18. [Proteases and their inhibitors in the pathogenesis of pulmonary emphysema]. Tishkin OG Arkh Patol; 1979; 41(3):66-70. PubMed ID: 311629 [No Abstract] [Full Text] [Related]